• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用脆弱性混合模型对疫苗效力进行可估计性分析与解释

Estimability and interpretation of vaccine efficacy using frailty mixing models.

作者信息

Halloran M E, Longini I M, Struchiner C J

机构信息

Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.

出版信息

Am J Epidemiol. 1996 Jul 1;144(1):83-97. doi: 10.1093/oxfordjournals.aje.a008858.

DOI:10.1093/oxfordjournals.aje.a008858
PMID:8659489
Abstract

The authors consider estimability and interpretation of vaccine efficacy based on time to event data, allowing that some of the population might have a very low probability of acquiring disease, and the rest have partial, possibly continuously distributed, susceptibility. The efficacy parameters of interest in the frailty mixing model include the fraction highly unlikely to acquire the infection or disease due to the vaccine, the degree of partial protection in those still susceptible, and the average protection or summary measure of efficacy under heterogeneity. The efficacy estimates can still be usefully interpreted when the heterogeneity results from heterogeneity in contact patterns, contact rates, or infectiousness of the contacts, as long as these are equal in the vaccinated and unvaccinated groups. A likelihood-based method allows estimation of the efficacy parameters of interest from grouped time to event data. Simulated vaccine studies assuming different levels and distributions of efficacy demonstrate that ignoring heterogeneity in susceptibility or exposure to infection generally results in underestimation of vaccine efficacy as well as incorrect interpretation of the estimates. The approach is also applicable to other covariates affecting susceptibility or exposure to infection in infectious diseases. Exploitation of the dependent happening structure of infectious diseases to obtain a shape for the baseline hazard may help identifiability. The authors recommend fitting several models to time to event data in vaccine studies.

摘要

作者基于事件发生时间数据考虑疫苗效力的可估计性和解释,假定部分人群感染疾病的概率很低,其余人群具有部分(可能呈连续分布)易感性。脆弱性混合模型中感兴趣的效力参数包括因疫苗而极不可能感染或患病的人群比例、仍易感人群中的部分保护程度,以及异质性情况下的平均保护或效力汇总指标。当异质性源于接触模式、接触率或接触者传染性的异质性时,只要接种组和未接种组中的这些因素相同,效力估计值仍可进行有益的解释。一种基于似然的方法可从分组的事件发生时间数据中估计感兴趣的效力参数。假设不同效力水平和分布的模拟疫苗研究表明,忽略易感性或感染暴露的异质性通常会导致疫苗效力估计值偏低以及对估计值的错误解释。该方法也适用于影响传染病易感性或感染暴露的其他协变量。利用传染病的相依发生结构来获得基线风险的形状可能有助于识别。作者建议在疫苗研究中对事件发生时间数据拟合多个模型。

相似文献

1
Estimability and interpretation of vaccine efficacy using frailty mixing models.使用脆弱性混合模型对疫苗效力进行可估计性分析与解释
Am J Epidemiol. 1996 Jul 1;144(1):83-97. doi: 10.1093/oxfordjournals.aje.a008858.
2
Interpretation and estimation of vaccine efficacy under heterogeneity.异质性条件下疫苗效力的解读与评估
Am J Epidemiol. 1992 Aug 1;136(3):328-43. doi: 10.1093/oxfordjournals.aje.a116498.
3
Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field.在实地评估预防性HIV疫苗时的暴露效果及接触率变化
Stat Med. 1994 Feb 28;13(4):357-77. doi: 10.1002/sim.4780130404.
4
Estimation and interpretation of heterogeneous vaccine efficacy against recurrent infections.针对复发性感染的异质性疫苗效力的评估与解读
Biometrics. 2016 Sep;72(3):976-85. doi: 10.1111/biom.12473. Epub 2016 Jan 20.
5
Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.风险率中随机产生的异质性对个体随机疫苗疗效试验的影响。
Clin Trials. 2018 Apr;15(2):207-211. doi: 10.1177/1740774517752671. Epub 2018 Jan 27.
6
Study designs for evaluating different efficacy and effectiveness aspects of vaccines.用于评估疫苗不同效力和效果方面的研究设计。
Am J Epidemiol. 1997 Nov 15;146(10):789-803. doi: 10.1093/oxfordjournals.aje.a009196.
7
Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.存在疫苗效力衰减情况下的疫苗效力评估:在霍乱疫苗中的应用
Am J Epidemiol. 1998 May 15;147(10):948-59. doi: 10.1093/oxfordjournals.aje.a009385.
8
Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations.在根据多个群体的易感性和传染性估计疫苗效力时的最佳疫苗试验设计。
Stat Med. 1998 May 30;17(10):1121-36. doi: 10.1002/(sici)1097-0258(19980530)17:10<1121::aid-sim824>3.0.co;2-e.
9
Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials.病例队列研究中分组生存数据的加权似然法及其在HIV疫苗试验中的应用
Biometrics. 2008 Dec;64(4):1247-55. doi: 10.1111/j.1541-0420.2008.00998.x.
10
On the distribution of vaccine protection under heterogeneous response.论异质性反应下疫苗保护的分布
Math Biosci. 1993 Jul;116(1):111-25. doi: 10.1016/0025-5564(93)90063-g.

引用本文的文献

1
Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics.疫苗失效模式决定了疫情期间疫苗接种运动对人群层面的影响。
J R Soc Interface. 2025 Feb;22(223):20240689. doi: 10.1098/rsif.2024.0689. Epub 2025 Feb 19.
2
Thirty-five years of leaky vaccines.35年的有缺陷疫苗。
Am J Epidemiol. 2025 Apr 8;194(4):918-920. doi: 10.1093/aje/kwae379.
3
Quantifying the Individual Variation in Susceptibility to Endemic Coronavirus and SARS-CoV-2 with Human Challenge Trials.用人体挑战试验量化对地方性冠状病毒和 SARS-CoV-2 易感性的个体差异。
Epidemiology. 2024 Jan 1;35(1):113-117. doi: 10.1097/EDE.0000000000001679. Epub 2023 Nov 27.
4
Competing Heterogeneities in Vaccine Effectiveness Estimation.疫苗效力估计中的竞争异质性
Vaccines (Basel). 2023 Aug 1;11(8):1312. doi: 10.3390/vaccines11081312.
5
Competing Heterogeneities in Vaccine Effectiveness Estimation.疫苗效力估计中的竞争异质性
ArXiv. 2023 May 12:arXiv:2305.01737v2.
6
Identification of Vaccine Effects When Exposure Status Is Unknown.当暴露状态未知时识别疫苗效果。
Epidemiology. 2023 Mar 1;34(2):216-224. doi: 10.1097/EDE.0000000000001573. Epub 2023 Jan 26.
7
A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues.关于新冠病毒疫苗策略、其有效性及相关问题的系统评价
Vaccines (Basel). 2021 Nov 24;9(12):1387. doi: 10.3390/vaccines9121387.
8
Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20.重点关注流感:通过对阴性对照结果的残余混杂因素评估,评估 2012/13 至 2019/20 年芬兰老年人的流感疫苗有效性。
Euro Surveill. 2021 Sep;26(36). doi: 10.2807/1560-7917.ES.2021.26.36.2100054.
9
Estimating vaccine efficacy over time after a randomized study is unblinded.在一项随机研究揭盲后,随着时间的推移估计疫苗效力。
Biometrics. 2022 Sep;78(3):825-838. doi: 10.1111/biom.13509. Epub 2021 Aug 13.
10
Interpreting vaccine efficacy trial results for infection and transmission.解读感染和传播疫苗效力试验结果。
Vaccine. 2021 Jul 5;39(30):4082-4088. doi: 10.1016/j.vaccine.2021.06.011. Epub 2021 Jun 12.